Status and phase
Conditions
Treatments
About
The purpose of this study is to test the safety of a study drug called PARPi-FL. This drug has been tested in animals but not yet in people. The purpose of this study is to test if a PARPi-FL scan can be used to take pictures of head and neck cancer. The usual approach to imaging this cancer includes several different imaging scans, including x-rays, CT (computed tomography), MRI (magnetic resonance imaging), and PET (positron emission tomography). These tests take pictures of the cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Part 1:
Part 2
Exclusion criteria
Significantly impaired organ function that may interfere with the excretion and metabolism of the imaging agent. Specifically, patients will be excluded if they meet the following criteria:
Hematologic
o Platelets <75K/mcL
Hepatic
Renal
o Creatinine > 2.0 x ULN
Claustrophobia interfering with PET/CT imaging
Primary purpose
Allocation
Interventional model
Masking
27 participants in 2 patient groups
Loading...
Central trial contact
Heiko Schöder, MD; Ravinder Grewal, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal